Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in Helicobacter pylori-positive gastric ulcer after eradication of infection

Journal of Clinical Gastroenterology

Volumn 25, Issue 1, 1997, Pages 317-322

  Ohkusa, Toshifumi ^a   Takashimizu, Ichizen ^a   Fujiki, Kazuhiko ^a   Araki, Akihiro ^a   Honda, Mkimio ^a   Shimoi, Kengo ^a   Sakurazawa, Toshiaki ^a   Horiuchi, Takao ^a   Suzuki, Shinji ^a   Ariake, Kouichiro ^a   Ishii, Kenichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Anti H. pylori IgG; Gastrin; Gastrit ulcer; H. pylori eradication; Pepsinogen I II ratio

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GASTRIN; IMMUNOGLOBULIN G; LANSOPRAZOLE; PEPSINOGEN I; PEPSINOGEN II; ROXITHROMYCIN;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MIXTURE; DUODENUM ULCER; FEMALE; GASTRIN BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STOMACH ULCER;

AGED; FEMALE; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPSINOGENS; STOMACH ULCER;

EID: 0031453445     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199707000-00004     Document Type: Article

References (35)

1. Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986;90:570-6.
2. Feldman M, Richardson CT, Lam SK, Samloff IM. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients. Gastroenterology 1988;95:630-5.
3. Taylor IL, Calam J, Rotter JI, et al. Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med 1981;95:421-5.
4. Samloff IM, Vans K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
5. Kekki M, Samloff IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;186(Suppl):S109-16.
6. Oderda G, Vaira D, Holton J, et al. Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 1991;36:572-6.
7. Chittajallu RS, Dorrian CA, Ardill JE, McColl KE. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992;27:20-4.
8. Hunter FM, Correa P, Fontham E, et al. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993;38:2081-6.
9. Chen TS, Tsay SH, Chang FY, Lee SD. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study. Am J Gastroenterol 1994;89:1511-4.
10. Wagner S, Haruma K, Gladziwa U, et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication [see comments]. Am J Gastroenterol 1994;89:1211-8.
11. Parente F, Maconi G, Sangaletti O, et al. Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients. A controlled study. Gut 1995;37:210-5.
12. Veenendaal RA, Pena AS, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991;32:1291-4.
13. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori [see comments]. Lancet 1992;339:893-5.
14. Cullen DJ, Cullen KJ, Collins BJ, et al. Serological assessment of Helicobacter pylori eradication [letter]. Lancet 1992;340:1161-2.
15. Cutler A, Schubert A, Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci 1993;38:2262-6.
16. Levi S, Beardshall K, Swift I, et al. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ 1989;299:1504-5.
17. Oderda G, Vaira D, Holton J, et al. Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1:690-2.
18. Graham DY, Opekun A, Lew GM, et al. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990;85:394-8.
19. Karnes WJ, Ohning GV, Sytnik B, Kim SW, Walsh JH. Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH. Rev Infect Dis 1991;13(Suppl 8):S665-70.
20. Smith JT, Pounder RE, Nwokolo CU, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990;31:522-5.
21. El-Nujumi AM, Dorrian CA, Chittajallu RS, et al. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 1991;32: 866-70.
22. El-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer [see comments]. Gut 1993;34:1060-5.
23. Chittajallu RS, Dorrian CA, Neithercut WD, Dahill S, McColl KE. Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut 1991;32: 1286-90.
24. Golodner EH, Soll AH, Walsh JH, Calam J. Release of gastrin from cultured canine G-cells by interferon-γ and tumor necrosis factor-α (Abstract). Gastroenterology 1993;104:A89.
25. Beales I, Srinivasan S, Blaser M, et al. Effect of Helicobacter pylori constituents and inflammatory cytokines on gastrin release from isolated canine G cells (Abstract). Gastroenterology 1995; 108:A779.
26. Kaneko H, Nakada K, Mitsuma T, et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992;37:409-16.
27. Queiroz DM, Mendes EN, Rocha GA, et al. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993;28:858-64.
28. Spiro H, Schwartz R. A cause of temporary achlorhydria and hyperpepsinemia. N Engl J Med 1958;256:682-4.
29. Samloff IM, Townes PI. Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum and gastric mucosa. Gastroenterology 1970;58:462.
30. Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971;61: 185-8.
31. Samloff IM, Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973;65:36-42.
32. Oderda G, Vaira D, Dell'Olio D, et al. Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori. J Clin Pathol 1990;43:762-5.
33. Fraser AG, Prewett EJ, Pounder RE, Samloff IM. Short report: twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive subjects is abolished by eradication of the infection. Aliment Pharmacol Ther 1992;6:389-94.
34. Cave TR, Cave DR. Helicobacter pylori stimulates pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol 1991;181(Suppl):S9-14.
35. Bayerdorffer E, Lehn N, Hatz R, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575-82.